Skip to main content

Table 4 Characteristics of the study population, N = 4926

From: Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences: the French E3N cohort

 

No. of women

Percentage

Age at breast cancer diagnosis

  < 50 years

647

13.1

 [50–60) years

2145

43.5

 [60–70) years

1712

34.8

  ≥ 70 years

422

8.6

Menopausal status at breast cancer diagnosis

 postmenopausal woman - more than 5 years of cumulated MHT use

1144

23.2

 postmenopausal woman - less than 5 years of cumulated MHT use

1205

24.5

 postmenopausal woman - no use of MHT

1314

26.7

 premenopausal woman

923

18.7

 Missing

340

6.9

recent MHT use before diagnosis

 yes

1914

38.9

 no

2932

59.5

 missing

80

1.6

Smoking status before diagnosis

 never smoker

2624

53.3

 current smoker

562

11.4

 ex-smoker

1717

34.9

 missing

23

0.5

Smoking status at first follow-up after diagnosis

 never smoker

2624

53.3

 current smoker

314

6.4

 ex-smoker

1664

33.8

 missing

324

6,6

Family history of breast cancer before diagnosis

 0

3959

80.4

 1

804

16.3

 2–4

98

1.0

 missing

65

1.3

History of benign breast disease before diagnosis

 Yes

2575

52.3

 No

2351

47.7

History of diabetes before diagnosis

 Yes

258

5.2

 No

4668

94.8

Level of education before diagnosis

  < high school level

568

11.5

 high school level-second year university level

2351

47.7

  > second year university level

1803

36.6

 Missing

204

4.1

Alcohol consumption at diagnosis

 Yes

4105

83.3

 no

523

10.6

Missing

298

6.0

BMI at diagnosis

 underweight (< 18.5)

132

2.7

 normal (18.5- < 25)

3255

66.1

 overweight (25- < 30)

1073

21.8

 obese (≥ 30)

264

5.3

 Missing

202

4.1

  1. MHT menopausal hormonal treatment, BMI Body Mass Index